NRX Pharmaceuticals, Inc. (NRXP)
4.445
+0.16
(+3.86%)
USD |
NASDAQ |
May 28, 16:00
4.40
-0.04
(-1.01%)
After-Hours: 17:22
NRX Pharmaceuticals Total Liabilities (Quarterly) : 25.72M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| IGC Pharma, Inc. | 3.064M |
| Definium Therapeutics, Inc. | 122.44M |
| Atai Beckley, Inc. | 66.10M |
| Alto Neuroscience, Inc. | 32.89M |
| LENZ Therapeutics, Inc. | 26.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.90M |
| Shareholders Equity (Quarterly) | -13.82M |
| Debt to Equity Ratio | -0.0676 |
| Current Ratio | 0.2924 |
| Net Debt Paydown Yield | 1.58% |